Anoro Ellipta and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Anoro Ellipta and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium / vilanterol
Brand name: Anoro Ellipta
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Anoro Ellipta-Insulin glargine, recombinant Subcutaneous
- Anoro Ellipta-Insulin glulisine
- Anoro Ellipta-Insulin Glulisine (Cartridges and Pens)
- Anoro Ellipta-Insulin Glulisine (Vials)
- Anoro Ellipta-Insulin glulisine Subcutaneous
- Anoro Ellipta-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Ansaid
- Insulin glargine and lixisenatide Subcutaneous-Antabuse
- Insulin glargine and lixisenatide Subcutaneous-Antagon
- Insulin glargine and lixisenatide Subcutaneous-Antara
- Insulin glargine and lixisenatide Subcutaneous-Anthrax vaccine
- Insulin glargine and lixisenatide Subcutaneous-Anthrax Vaccine Adsorbed